Lovett Evan Reddick has joined GSK as the Executive Director for Emerging Therapeutic Areas within US Medical Oncology. Expressing gratitude for his previous role at Takeda, he highlighted the meaningful connections he fostered there. Personally motivated by his mother’s battle with breast cancer, Reddick is committed to developing oncology programs that enhance patient care and extend quality time for families. He looks forward to collaborating across various teams to bridge scientific advancements with clinical applications in his new role at GSK.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://oncodaily.com/career/lovett-evan-reddick544516
